Inventor · disambiguated record
Arun Thottumkara
Also filed as: THOTTUMKARA ARUN · THOTTUMKARA ARUN P
14 granted patents·16 pending applications·37 citations·filing 2003–2024
89Inventor score
Files withDENALI THERAPEUTICS INC16REVOLUTION MEDICINES INC7NICO THERAPEUTICS INC4SFUNGA THERAPEUTICS INC2TRUSTEES OF WESTERN ILLINOIS U1
Top patents by PatentIndex Score
30 records- 0195US11685749B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Jun 27, 2023·5 cites·8 claims
- 0295US10980889B1C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2020·Granted Apr 20, 2021·8 cites·6 claims
- 0394US12187746B2C26-linked rapamycin analogs as mTOR inhibitorsREVOLUTION MEDICINES INC·Filed 2023·Granted Jan 7, 2025·5 cites·9 claims
- 0491US11306077B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Apr 19, 2022·2 cites·47 claims
- 0589US9957290B2Derivatives of amphotericin BREVOLUTION MEDICINES INC·Filed 2016·Granted May 1, 2018·8 cites·18 claims
- 0683US11203600B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2019·Granted Dec 21, 2021·2 cites·24 claims
- 0783US10597420B2Derivatives of amphotericin BSFUNGA THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·20 claims
- 0880US10882883B2Derivatives of amphotericin BSFUNGA THERAPEUTICS INC·Filed 2020·Granted Jan 5, 2021·1 cites·24 claims
- 0980US2025011338A1Kinase Inhibitors and Uses ThereofDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1076US2023250072A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1175US2025122159A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1269US12180211B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Granted Dec 31, 2024·0 cites·5 claims
- 1369US12129263B2Kinase inhibitors and uses thereofDENALI THERAPEUTICS INC·Filed 2021·Granted Oct 29, 2024·0 cites·19 claims
- 1468US11958840B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Granted Apr 16, 2024·0 cites·45 claims
- 1568US2019336609A1C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR InhibitorsREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 1665US11072618B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2019·Granted Jul 27, 2021·0 cites·17 claims
- 1764US2021130308A1Modulators of eukaryotic initiation factor 2DENALI THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1864US2023093861A1Rapamycin analogs as mtor inhibitorsREVOLUTION MEDICINES INC·Filed 2022·Application pending·0 cites
- 1961US2025361234A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2060US12091392B2Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2020·Granted Sep 17, 2024·0 cites·9 claims
- 2160US2021094975A1Rapamycin analogs as mtor inhibitorsREVOLUTION MEDICINES INC·Filed 2019·Application pending·0 cites
- 2259US2025171462A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2359US2025145592A1Compounds, compositions, and methodsNICO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2458US2024391932A1Compounds, compositions and methodsNICO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2558US2024254132A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2654US2023357162A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2753US2023348437A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2853US2023416205A1Compounds, compositions, and methodsDENALI THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2950US6933405B2User- and eco-friendly hypervalent iodine reagent and method of synthesisTRUSTEES OF WESTERN ILLINOIS U·Filed 2003·Granted Aug 23, 2005·2 cites·7 claims
- 3049US2022177456A1Compounds, compositions and methodsDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →